<SEC-DOCUMENT>0001104659-26-017298.txt : 20260219
<SEC-HEADER>0001104659-26-017298.hdr.sgml : 20260219
<ACCEPTANCE-DATETIME>20260219084235
ACCESSION NUMBER:		0001104659-26-017298
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20260219
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20260219
DATE AS OF CHANGE:		20260219

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Traws Pharma, Inc.
		CENTRAL INDEX KEY:			0001130598
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36020
		FILM NUMBER:		26651630

	BUSINESS ADDRESS:	
		STREET 1:		12 PENNS TRAIL
		CITY:			NEWTOWN
		STATE:			PA
		ZIP:			18940
		BUSINESS PHONE:		267-759-3680

	MAIL ADDRESS:	
		STREET 1:		12 PENNS TRAIL
		CITY:			NEWTOWN
		STATE:			PA
		ZIP:			18940

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Onconova Therapeutics, Inc.
		DATE OF NAME CHANGE:	20090526

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ONCONOVA THERAPEUTICS, INC.
		DATE OF NAME CHANGE:	20090526

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ONCONOVA THERAPEUTICS INC
		DATE OF NAME CHANGE:	20001226
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>tm266824d1_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:us-roles="http://fasb.org/us-roles/2025" xmlns:country="http://xbrl.sec.gov/country/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:tmb="http://onconova.com/20260219">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02E_US%2DGAAP%2D2025 -->
<!-- Field: Set; Name: xdx; ID: xdx_034_tmb_onconova.com_20260219 -->
<!-- Field: Set; Name: xdx; ID: xdx_04E_20260219_20260219 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_052_edei%2D%2DEntityCentralIndexKey_0001130598 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2026-02-19" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2026-02-19" id="Fact000004" name="dei:EntityCentralIndexKey">0001130598</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="tmb-20260219.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2026-02-19">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001130598</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2026-02-19</xbrli:startDate>
        <xbrli:endDate>2026-02-19</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNITED STATES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Washington, DC 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM <span id="xdx_90B_edei--DocumentType_c20260219__20260219_zV0ZOVEnHxF6"><ix:nonNumeric contextRef="AsOf2026-02-19" id="Fact000009" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CURRENT REPORT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PURSUANT TO SECTION&#160;13 OR 15(d)&#160;OF
THE</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SECURITIES EXCHANGE ACT OF 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Date of Report (Date of earliest event reported):
<span id="xdx_905_edei--DocumentPeriodEndDate_c20260219__20260219_zHMiutCU7sci"><ix:nonNumeric contextRef="AsOf2026-02-19" format="ixt:datemonthdayyearen" id="Fact000010" name="dei:DocumentPeriodEndDate">February 19, 2026</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 16pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_909_edei--EntityRegistrantName_c20260219__20260219_zP9Bv1mULsFc"><b><ix:nonNumeric contextRef="AsOf2026-02-19" id="Fact000011" name="dei:EntityRegistrantName">Traws
Pharma, Inc.</ix:nonNumeric></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact name of Registrant as specified in its
charter)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="vertical-align: top; width: 32%; text-align: center"><b><span id="xdx_906_edei--EntityIncorporationStateCountryCode_c20260219__20260219_zM5l3THCCv15"><ix:nonNumeric contextRef="AsOf2026-02-19" format="ixt-sec:stateprovnameen" id="Fact000012" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></td>
    <td style="vertical-align: bottom; width: 2%">&#160;</td>
    <td style="vertical-align: top; width: 32%; text-align: center"><b><span id="xdx_909_edei--EntityFileNumber_c20260219__20260219_zk69QnVYxl72"><ix:nonNumeric contextRef="AsOf2026-02-19" id="Fact000013" name="dei:EntityFileNumber">001-36020</ix:nonNumeric></span></b></td>
    <td style="vertical-align: bottom; width: 2%">&#160;</td>
    <td style="vertical-align: top; width: 32%; text-align: center"><b><span id="xdx_90D_edei--EntityTaxIdentificationNumber_c20260219__20260219_z9OWW9KN6NGd"><ix:nonNumeric contextRef="AsOf2026-02-19" id="Fact000014" name="dei:EntityTaxIdentificationNumber">22-3627252</ix:nonNumeric></span></b></td></tr>
  <tr>
    <td style="vertical-align: top; text-align: center">(State or Other Jurisdiction<br/>
    of Incorporation or Organization)</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: center">(Commission<br/>
    File Number)</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: center">(I.R.S. Employer<br/>
    Identification No.)</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="vertical-align: bottom; width: 100%; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_90D_edei--EntityAddressAddressLine1_c20260219__20260219_zBiP3GY7Kz0g"><ix:nonNumeric contextRef="AsOf2026-02-19" id="Fact000015" name="dei:EntityAddressAddressLine1">12 Penns Trail</ix:nonNumeric></span></b></p>

<b><span id="xdx_905_edei--EntityAddressCityOrTown_c20260219__20260219_ztLYZkNblfbh"><ix:nonNumeric contextRef="AsOf2026-02-19" id="Fact000016" name="dei:EntityAddressCityOrTown">Newtown</ix:nonNumeric></span>, <span id="xdx_906_edei--EntityAddressStateOrProvince_c20260219__20260219_zf46j9VP1Oi4"><ix:nonNumeric contextRef="AsOf2026-02-19" id="Fact000017" name="dei:EntityAddressStateOrProvince">PA</ix:nonNumeric></span> <span id="xdx_904_edei--EntityAddressPostalZipCode_c20260219__20260219_z7NiD2zH3woh"><ix:nonNumeric contextRef="AsOf2026-02-19" id="Fact000018" name="dei:EntityAddressPostalZipCode">18940</ix:nonNumeric></span></b></td>
    </tr>
<tr>
    <td style="vertical-align: bottom; text-align: center"><b>(<span id="xdx_90C_edei--CityAreaCode_c20260219__20260219_zPIyNXf7Z9R3"><ix:nonNumeric contextRef="AsOf2026-02-19" id="Fact000019" name="dei:CityAreaCode">267</ix:nonNumeric></span></b><b>)
    <span id="xdx_90D_edei--LocalPhoneNumber_c20260219__20260219_zacHQccI9Tia"><ix:nonNumeric contextRef="AsOf2026-02-19" id="Fact000020" name="dei:LocalPhoneNumber">759-3680</ix:nonNumeric></span></b></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-size: 10pt">(Address,
Including Zip Code, and Telephone Number, Including Area Code, of Registrant&#8217;s Principal Executive <br/>
Offices)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b>Not Applicable&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Former name or former address, if changed since
last report)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Check the appropriate box below if the Form&#160;8-K
is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.4in; text-align: left"><span id="xdx_901_edei--WrittenCommunications_c20260219__20260219_zbBszdKvJNgi" style="font-family: Wingdings"><ix:nonNumeric contextRef="AsOf2026-02-19" format="ixt:booleanfalse" id="Fact000021" name="dei:WrittenCommunications">&#168;</ix:nonNumeric></span></td><td style="text-align: justify">Written
                                            communications pursuant to Rule&#160;425 under the Securities Act (17 CFR 230.425)</td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.4in; text-align: left"><span id="xdx_909_edei--SolicitingMaterial_c20260219__20260219_z8MTe9OMobyj" style="font-family: Wingdings"><ix:nonNumeric contextRef="AsOf2026-02-19" format="ixt:booleanfalse" id="Fact000022" name="dei:SolicitingMaterial">&#168;</ix:nonNumeric></span></td><td style="text-align: justify">Soliciting
                                            material pursuant to Rule&#160;14a-12 under the Exchange Act (17 CFR 240.14a-12)</td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.4in; text-align: left"><span id="xdx_90C_edei--PreCommencementTenderOffer_c20260219__20260219_zrgYQD9x2hb9" style="font-family: Wingdings"><ix:nonNumeric contextRef="AsOf2026-02-19" format="ixt:booleanfalse" id="Fact000023" name="dei:PreCommencementTenderOffer">&#168;</ix:nonNumeric></span></td><td style="text-align: justify">Pre-commencement
                                            communications pursuant to Rule&#160;14d-2(b)&#160;under the Exchange Act (17 CFR 240.14d-2(b))</td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.4in; text-align: left"><span id="xdx_90A_edei--PreCommencementIssuerTenderOffer_c20260219__20260219_zyC9zizKi0sl" style="font-family: Wingdings"><ix:nonNumeric contextRef="AsOf2026-02-19" format="ixt:booleanfalse" id="Fact000024" name="dei:PreCommencementIssuerTenderOffer">&#168;</ix:nonNumeric></span></td><td style="text-align: justify">Pre-commencement
                                            communications pursuant to Rule&#160;13e-4(c)&#160;under the Exchange Act (17 CFR 240.13e-4(c))</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Securities registered pursuant to Section&#160;12(b)&#160;of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding: 1pt; width: 40%; text-align: center"><span style="font-size: 10pt"><b>Title&#160;of&#160;each&#160;class</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding: 1pt; width: 20%; text-align: center"><span style="font-size: 10pt"><b>Trading&#160;Symbol(s)</b></span></td>
    <td style="border: Black 1pt solid; padding: 1pt; width: 40%; text-align: center"><span style="font-size: 10pt"><b>Name&#160;of&#160;each&#160;exchange&#160;on&#160;which&#160;registered</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding: 1pt; text-align: center"><span id="xdx_90F_edei--Security12bTitle_c20260219__20260219_z83o0WEYhzFf" style="font-style: normal; font-weight: normal"><ix:nonNumeric contextRef="AsOf2026-02-19" id="Fact000025" name="dei:Security12bTitle">Common
    stock, par value $.01 per share</ix:nonNumeric></span></td>
    <td style="border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding: 1pt; text-align: center"><span id="xdx_90C_edei--TradingSymbol_c20260219__20260219_zPqcJT93DoHf" style="font-style: normal; font-weight: normal"><ix:nonNumeric contextRef="AsOf2026-02-19" id="Fact000026" name="dei:TradingSymbol">TRAW</ix:nonNumeric></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding: 1pt; text-align: center"><span id="xdx_904_edei--SecurityExchangeName_c20260219__20260219_zBAHmwOm3G3k" style="font-style: normal; font-weight: normal"><ix:nonNumeric contextRef="AsOf2026-02-19" format="ixt-sec:exchnameen" id="Fact000027" name="dei:SecurityExchangeName">The
    Nasdaq Stock Market LLC</ix:nonNumeric></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule&#160;405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule&#160;12b-2
of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Emerging growth company&#160;&#160;<span id="xdx_902_edei--EntityEmergingGrowthCompany_c20260219__20260219_zNz0pQXktVN9" style="font-family: Wingdings"><ix:nonNumeric contextRef="AsOf2026-02-19" format="ixt:booleanfalse" id="Fact000028" name="dei:EntityEmergingGrowthCompany">&#168;</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="font-family: Wingdings">&#168;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Item 8.01. Other Events.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">On February 19, 2026,
Traws Pharma,&#160;Inc. (the &#8220;Company&#8221;) issued a press release (the &#8220;Press Release&#8221;) announcing the completion
of its analysis of its study of ratutrelvir, a ritonavir-free treatment, in PAXLOVID&#174;-eligible and ineligible patients with mild-to-moderate
COVID-19 and updates for additional indication for tivoxavir marboxil as a prophylactic treatment for seasonal influeza. A copy of the
Press Release is filed as Exhibit&#160;99.1 to this Current Report on Form&#160;8-K (this &#8220;Current Report&#8221;) and is incorporated
by reference into this Item 8.01.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b><i>Forward-Looking
Statements</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">This Current Report,
including Exhibit&#160;99.1, contains certain forward-looking statements that involve substantial risks and uncertainties. When used herein,
the terms &#8220;anticipates,&#8221; &#8220;expects,&#8221; &#8220;estimates,&#8221; &#8220;believes,&#8221; &#8220;will&#8221; and similar
expressions, as they relate to the Company or its management, are intended to identify such forward-looking statements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Forward-looking statements
in this Current Report, including Exhibit&#160;99.1, or hereafter, including in other publicly available documents filed with the Securities
and Exchange Commission, reports to the stockholders of the Company and other publicly available statements issued or released by the
Company involve known and unknown risks, uncertainties and other factors which could cause the Company&#8217;s actual results, performance
(financial or operating) or achievements to differ from the future results, performance (financial or operating) or achievements expressed
or implied by such forward-looking statements. Such future results are based upon management&#8217;s best estimates based upon current
conditions and the most recent results of operations. These risks include, but are not limited to, the risks set forth herein and in such
other documents filed with the Securities and Exchange Commission, each of which could adversely affect the Company&#8217;s business and
the accuracy of the forward-looking statements contained herein.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Item 9.01. Financial
Statements and Exhibits.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">(d)&#160;Exhibits.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <tr>
    <td style="vertical-align: top; width: 8%; text-align: justify"><span style="font-size: 10pt"><b>Exhibit&#160;No.</b></span></td>
    <td style="vertical-align: top; width: 2%; padding-bottom: 1pt; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; width: 90%; text-align: justify"><span style="font-size: 10pt"><b>Description</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><a href="tm266824d1_ex99-1.htm" style="-sec-extract: exhibit"><span style="font-size: 10pt">99.1</span></a></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><a href="tm266824d1_ex99-1.htm" style="-sec-extract: exhibit"><span style="font-size: 10pt">Press Release, dated February 19, 2026.</span></a></td></tr>
  <tr>
    <td style="vertical-align: bottom; text-align: justify"><span style="font-size: 10pt">104</span></td>
    <td style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: justify"><span style="font-size: 10pt">Cover Page&#160;Interactive Data File (embedded within the inline XBRL Document)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"></span>&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: #212529"><b>SIGNATURES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; color: #212529">Pursuant to the requirements
of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date: February 19, 2026</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TRAWS PHARMA,&#160;INC.</b></span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="width: 50%">&#160;</td>
    <td style="width: 3%">&#160;</td>
    <td style="width: 47%">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Iain Dukes</span></td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Iain Dukes</span></td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"></p>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"></span>&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjU0KwkAMhU/QO4RZS38GXdilpYpYpZQibkcbZbCdlMz4dyRv6dgihkAI733vCTERK1rqFhkOi6qAGru+VQ6hwjMymhN6R7bepOBvhRdtHSvjhvcHZuQZ9MwslPLohcF61xabFOJZJJNITiGepnIO5VYEXz0jc9YNGqdVC8o0UDL1rNEpfo0JtXqSoe41VO2RrSaTQhLGo/wGGScSdnRXD+KrhaLIRDAZJhArplvvXfnTofmSkLfY+To70v8NPgiWSpA= -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>tm266824d1_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0"><B>Exhibit 99.1</B></P>

<P STYLE="margin: 0; text-align: left">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0; text-align: center"><IMG SRC="tm266824d1_ex99-1img001.jpg" ALT="" STYLE="height: 65px; width: 200px">&nbsp;</P>

<P STYLE="margin: 0; text-align: left">&nbsp;</P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>Traws Pharma
Completes Analysis of Ratutrelvir Clinical Study in PAXLOVID<I><SUP>&reg;</SUP></I>-Eligible and Ineligible COVID-19 Patients and Provides
Updates for Additional Indication for Tivoxavir Marboxil as a Prophylactic Treatment for Seasonal Influenza</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><I>Completed clinical
results with <B>ratutrelvir</B> confirm a differentiated profile versus PAXLOVID</I></FONT><I><SUP>&reg;</SUP> with fewer adverse events
and no viral rebounds with equivalent time to sustained symptom resolution; results were recapitulated in PAXLOVID<SUP>&reg;</SUP>-ineligible
patients, representing a significant population with no effective treatment options</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>Pre-clinical analysis of <B>tivoxavir marboxil</B>
tablets demonstrated significantly increased exposure compared to a prototype formulation with predicted 28-day protection in humans from
influenza infections against a wide range of seasonal and pandemic variants</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>PK study of compressed <B>tivoxavir marboxil</B>
tablets submitted under open IND in Australia and preparations are underway for a Human Influenza Prophylaxis Challenge Study in the UK</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">NEWTOWN, PA, February&nbsp;19, 2026 (GLOBENEWSWIRE)
-- Traws Pharma,&nbsp;Inc. (NASDAQ: TRAW, &ldquo;Traws Pharma&rdquo;, &ldquo;Traws&rdquo; or &ldquo;the Company&rdquo;), a clinical-stage
biopharmaceutical company developing novel therapies to target critical threats to human health from respiratory viral diseases, today
announced the completion of the clinical analysis of its 90-patient, open-label Phase 2 study of ratutrelvir, an investigational oral,
ritonavir-free Mpro/3CL protease inhibitor, versus PAXLOVID<SUP>&reg;</SUP> in patients with mild-to-moderate COVID-19, together with
a single arm in PAXLOVID<SUP>&reg;</SUP>-ineligible subjects. Patients ineligible to receive PAXLOVID<SUP>&reg;</SUP> are frequently at
elevated risk for severe disease and require suitable, safe and effective treatment options. Ratutrelvir has the potential to address
this gap in care and may be a valuable therapeutic option.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Ratutrelvir Update</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Designed as an active-controlled comparator trial
versus PAXLOVID<SUP>&reg;</SUP> (nirmatrelvir/ritonavir), the study evaluated patient-reported symptom outcomes, safety, and real-world
usability. A separate treatment arm was comprised of patients ineligible for ritonavir-boosted regimens due to contraindications or clinically
significant drug&ndash;drug interactions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Patients in the ratutrelvir arm received ratutrelvir
600 mg orally once daily for 10 days, while patients in the comparator arm received PAXLOVID<SUP>&reg;</SUP>, administered as nirmatrelvir
300 mg twice daily plus 100mg ritonavir twice daily for 5 days, consistent with approved prescribing information. Patients receiving ratutrelvir
who were ineligible for PAXLOVID<SUP>&reg;</SUP> reported fewer treatment-related adverse events (3 events in 30 subjects, 10%) compared
to subjects receiving PAXLOVID<SUP>&reg;</SUP>, (7 events in 30 subjects, 23.3%), and symptoms resolved more quickly in subjects taking
ratutrelvir who were ineligible for PAXLOVID<SUP>&reg;</SUP>, compared to PAXLOVID<SUP>&reg;</SUP> treatment (HR, 1.31; 95% CI, 0.78-2.20,
<I>p</I>=0.018).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;From a clinical perspective, the completed
data analysis confirms that ratutrelvir may provide a meaningful benefit across a broader range of patients, including those who are unable
to receive ritonavir-boosted therapy,&rdquo; commented <B>Robert R. Redfield, MD, Chief Medical Officer </B>of Traws Pharma. &ldquo;The
favorable tolerability profile, together with a shortened time to symptom resolution and the absence of viral rebound events in ratutrelvir-treated
patients, encourages and supports the continued clinical evaluation of ratutrelvir in both acute COVID-19 and in studies designed to better
understand its potential impact on longer-term outcomes.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;The combination of early and sustained
symptom improvement, extended dosing duration, absence of viral rebound observed to date, and favorable tolerability supports the strategic
hypothesis that ratutrelvir may have utility in reducing post-acute sequelae of SARS-CoV-2 infection (Long COVID),&rdquo; commented <B>Dr.&nbsp;Redfield</B>.
&ldquo;By enabling earlier and potentially more complete viral clearance, without the limitations associated with ritonavir boosting,
ratutrelvir may offer a differentiated approach to both acute COVID-19 treatment and prevention of longer-term complications&rdquo;.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Tivoxavir Marboxil Update</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company additionally announced progress in
advancing an additional indication for tivoxavir marboxil (TXM), a potential best in class CAP-dependent endonuclease inhibitor, as a
once-monthly, single oral tablet for prevention of seasonal influenza.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In prior Phase 1 studies in healthy volunteers,
an unformulated powder-in-capsule formulation provided blood levels exceeding 3X EC<SUB>50</SUB> against a basket of common seasonal influenza
variants up to 22 days after drug administration. A tablet formulation has been evaluated pre-clinically and demonstrated a 30% increase
in exposure compared to the unformulated prototype. &ldquo;Modelling of these data suggests that the tablet formulation should provide
28-day coverage, enabling a once-a-month prophylactic treatment,&rdquo; commented <B>C. David Pauza, PhD, Chief Science Officer</B> of
Traws Pharma. &ldquo;We intend to advance these findings into a healthy volunteer study to be conducted under an open IND in Australia
and, if the extended exposure is confirmed, we intend to progress TXM into a Seasonal Human Influenza Virus Prophylaxis Challenge Study,&rdquo;
<B>Dr.&nbsp;Pauza</B> continued.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Separately, the FDA informed the Company that
its US IND for tivoxavir marboxil was being placed on clinical hold due to concerns with the mutagenicity data package. The FDA intends
to communicate its concerns formally, together with suggested mitigation steps, by March&nbsp;16, 2026. <B>Dr.&nbsp;Redfield</B> commented,
&ldquo;This IND application was originally filed to enable a complete review by the Biomedical Advanced Research and Development Authority
(BARDA) of the Company&rsquo;s application for inclusion in the strategic stockpile for the treatment of avian influenza. While the clinical
hold does not directly impact ongoing and planned studies outside of the United States, Traws Pharma appreciates the FDA concern and is
working to mitigate this issue in our clinical development plan.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;Collectively, the advancement of our antiviral
portfolio provides a number of significant value inflection points and could provide treatment and prevention options for clinically important
viral diseases,&rdquo; commented <B>Iain Dukes, MA, DPhil, Chief Executive Officer</B> of Traws Pharma.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>About Ratutrelvir</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Ratutrelvir is an investigational oral, small
molecule Mpro (3CL protease) inhibitor designed to be a broadly acting treatment for SARS-CoV-2/COVID-19 that is used without ritonavir.
It has demonstrated <I>in vitro</I> activity against a range of virus strains. Preclinical and Phase 1 studies show that ratutrelvir does
not require co-administration with a metabolic inhibitor, such as ritonavir, which could avoid ritonavir-associated drug-drug interactions<SUP>1</SUP>,
and potentially enable wider patient use. Phase 1 data also show that ratutrelvir&rsquo;s pharmacokinetic (PK) profile demonstrated maintenance
of target blood plasma levels approximately 13 times above the EC<SUB>50</SUB> using the target Phase 2 dosing regimen of 600 mg/day for
ten days, which may also reduce the likelihood of clinical rebound and, consequently, reduce the risk for Long COVID<SUP>2</SUP>. Industry
data indicate that COVID treatment represents a potential multi-billion dollar market opportunity<SUP>3</SUP>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>About Tivoxavir Marboxil</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Tivoxavir marboxil (TXM) is an investigational
oral, small molecule CAP-dependent endonuclease inhibitor designed to be administered as a single-dose for the treatment of bird flu and
seasonal influenza. It has shown potent <I>in vitro</I> activity against a range of influenza strains in preclinical studies, including
a human isolate of the highly pathogenic avian flu H5N1 (bird flu). Consistent, positive preclinical data from three animal species indicate
that a single dose of TXM demonstrated a therapeutic effect against H5N1 bird flu. Seasonal influenza represents an estimated multi-billion
dollar antiviral market opportunity, largely driven by global health organizations, practice guidelines and government tenders and inclusion
in drug stock piling initiatives<SUP>4,5</SUP>, with upside potential from potential pandemic flu outbreaks including H5N1 bird flu. We
believe that these data support further development of TXM as a treatment for bird flu.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Source information</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">1.</TD><TD><U>https://ascpt.onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.2646</U></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">2.</TD><TD>Carly Herbert et al. (2025) Clinical Infectious Diseases. <U>https://pubmed.ncbi.nlm.nih.gov/39692474/</U></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">3.</TD><TD>Pfizer Inc. annual report on Form&nbsp;10-K for the fiscal year ended
                                            December&nbsp;31, 2025, filed with the U.S. Securities and Exchange Commission on February&nbsp;
                                            3, 2026</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">4.</TD><TD><U>Per link</U></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">5.</TD><TD>TRAW data on file</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Third-party products mentioned herein are the
trademarks of their respective owners.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>About Traws Pharma,&nbsp;Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Traws Pharma is a clinical stage biopharmaceutical
company dedicated to developing novel therapies to target critical threats to human health in respiratory viral diseases. Traws integrates
antiviral drug development, medical intelligence and regulatory strategy to meet real world challenges in the treatment of viral diseases.
We are advancing novel investigational oral small molecule antiviral agents that have potent activity against difficult to treat or resistant
virus strains that threaten human health: COVID-19/Long COVID and bird flu and seasonal influenza. Ratutrelvir is in development as a
ritonavir-independent COVID treatment, targeting the Main protease (Mpro or 3CL protease). Tivoxavir marboxil is in development as a
single dose treatment for bird flu and seasonal influenza, targeting the influenza cap-dependent endonuclease (CEN).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Traws is actively seeking development and commercialization
partners for its legacy clinical oncology programs, rigosertib and narazaciclib. More details can be found on Traws&rsquo; website at
<U>https://www.ir.trawspharma.com/partnering</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For more information, please visit www.trawspharma.com
and follow us on LinkedIn.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Forward-Looking Statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Some of the statements in this release are forward-looking
statements within the meaning of Section&nbsp;27A of the Securities Act of 1933, as amended, Section&nbsp;21E of the Securities Exchange
Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995, and involve risks and uncertainties including statements
regarding the Company, its business and product candidates, including the potential opportunity, market size, benefits, effectiveness,
safety, and the clinical and regulatory plans for ratutrelvir and tivoxavir marboxil, as well as plans for its legacy programs. The Company
has attempted to identify forward-looking statements by terminology including &ldquo;believes&rdquo;, &ldquo;estimates&rdquo;, &ldquo;anticipates&rdquo;,
&ldquo;expects&rdquo;, &ldquo;plans&rdquo;, &ldquo;intends&rdquo;, &ldquo;may&rdquo;, &ldquo;could&rdquo;, &ldquo;might&rdquo;, &ldquo;will&rdquo;,
&ldquo;should&rdquo;, &ldquo;preliminary&rdquo;, &ldquo;encouraging&rdquo;, &ldquo;approximately&rdquo; or other words that convey uncertainty
of future events or outcomes. Although Traws believes that the expectations reflected in such forward-looking statements are reasonable
as of the date made, expectations may prove to have been materially different from the results expressed or implied by such forward looking
statements. These statements are only predictions and involve known and unknown risks, uncertainties, and other factors, including the
outcome of Traws&rsquo; IND filing with the FDA, including the current FDA clinical hold for tivoxavir marboxil; the success and timing
of Traws&rsquo; clinical trials; the potential efficacy of ratutrelvir for the treatment of COVID-19, including the potential to reduce
the risk of COVID rebound and Long COVID; the potential for ratutrelvir to gain market acceptance, if and when regulatory approval is
obtained, or to become the new standard of care; Traws&rsquo; interactions with the FDA, BARDA and similar foreign regulators; collaborations;
market conditions; regulatory requirements and pathways for approval; the ongoing need for improved therapy to reduce the frequency of
clinical rebound and the concomitant risk for Long COVID; the extent of the spread and threat of the bird flu; the Company&rsquo;s cash
projections; Traws&rsquo; ability to raise additional capital when needed; and those discussed under the heading &ldquo;Risk Factors&rdquo;
in Traws&rsquo; filings with the U.S. Securities and Exchange Commission (SEC). Any forward-looking statements contained in this release
speak only as of its date. Traws undertakes no obligation to update any forward-looking statements contained in this release to reflect
events or circumstances occurring after its date or to reflect the occurrence of unanticipated events, except to the extent required by
law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Traws Pharma Contact:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Charles Parker</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Traws Pharma,&nbsp;Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>cparker@trawspharma.com</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">www.trawspharma.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Investor Contact:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">John Fraunces<BR>
LifeSci Advisors, LLC<BR>
917-355-2395<BR>
<U>jfraunces@lifesciadvisors.com</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 5; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>tm266824d1_ex99-1img001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm266824d1_ex99-1img001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !Y 74# 2(  A$! Q$!_\0
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M]5[*'8#T*/XN:P#^]T^Q<>B[U_J:U[/XO6C%1>Z5/%ZM#('_ $.*\OBT^]G
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MM8/^N4*K_(59DECAC,DKJB#JS' %8=[XU\.6&X2ZM;LR]5A/F'_QW-9WG+S
MWZ*X&Y^+.B19%O:7LY[':J#]3G]*Q[CXOW!)%MH\:CL99R?T '\ZI49OH!ZM
M5*]T?3=2&+VPMKCT,L08CZ$UY-+\6->;_5VUA'_VS8_^S5 WQ2\2'H;)?I ?
M_BJI4)@=WJ'PTT.X_>Z?Y^FW2G='+!(Q"L.AVD_R(K4TB37-/VV6M".[0<1Z
MA!QN]I$_A/N,CUQW\TC^*OB%"-\=C(/>)A_)JT;;XOW:D"ZTB!QW,4Q7]"#5
M.G4:L]0/6**XC3_BEH%V56Y%Q9N>\B;E_-<_RKK[*_M-1MEN+*YBN(6Z/&P8
M5A*,H[H"Q1114@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !111TH *9+-%;Q-+-(D<:#+.[ !1ZDFN*\0?$S2]+9[?3U^WW2G!*
MG$:GW;O^'YUY;KWB74_$=SYM_.3&#\D"9$:?1<]?<\UM"C*6^@'I'B/XHV=B
M3;Z*B7LW>9B1$I]O[_X8'O7F>K^(=5UV3?J-Y),H.5C^ZB_11Q^/6LRBNN%.
M,=A!1116@!0 2P4 DDX '<UT?A_P3K'B'9+#$(+-O^7F;A2/]D=6_E[UZWX:
M\%Z7X;B#11BXO/XKJ11N^B_W1]/QS64ZL8^H'G7AKX::AJI%QJOF6%KP0I4>
M:_X'[OXC/M7J6C>&M)T&/;I]FB/C#2M\TC?5CS^'2M&XN8+2%IKF:.&)>KR,
M% _$UQNL_$_1=/5DL=^H3CIY?RQY]V/] :Y7*=389V]4-1UK3-(3=J%_;V^1
MD+(X#-]!U/X5XUJOQ'\1:EN6.Y6RB/\ #;+@_P#?1R?RQ7)NS22-([%G8Y9F
M.23ZDUI'#O[3 ]?U/XLZ7;LR:;:3WI'1V/E(?S!;]!7(ZG\3?$-^2MO)%8Q^
MD"98_5FS^F*XVBMHTH+H(LWFH7NH/OO;N>Y;.<S2%L?G5:BI[.RNM0G$%G;2
MW$I_AB0L?QQTK78""BN]TOX4ZQ=;7U"X@LD/51^\?\AQ^M=KIGPU\.V"J9K=
M[V4=7N')!_X",#\P:QE6@@/$8()KJ7RK>&2:3^Y$A8_D*WK'P+XEOP#'I4L2
MG^*X(BQ^#<_I7O-M9VUE$(K2WA@C'1(D"C\A4U9/$/HAGC5O\)M<DP9[JQA!
MZX=F(_#;C]:OK\'[G^+6HA]+<G_V:O520!DG ]ZC:Y@7[TT8^KBL_;3 \L?X
M07@'[O6(&/\ M0$?U-54^'_C#0YS<Z5=1-(.]M.4+>Q#  _0\5ZZ+F!ONS1G
MZ,*D#!AE2"/44>VGU X70_&UY9W":;XOMFL+ESB&Z=-L<GL3T!]QQ]._=@Y&
M14=Q;P7<+0W,,<T3##)(H93]0:KV&GQZ;'Y%LS"U'W(F8L(_92>0/;H.V*B3
M3U6@%RBBBH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HK'USQ
M1I/AZ/-_= 2D96!/FD;Z#M]3@5Y3XE^(VIZT&M[+=86?<1O^\D'^TPZ#V'YF
MM(4I2 ])\1>.-(\/I)&TRW-ZO MHCD@_[1Z+^//M7DNO>-M:U\M'-<>1:G_E
MW@.U2/<]6_'CVKG:*[(4HQ$%%%%:@%%:.D:#J>NSF'3;1YBI^=^B)]6/ ^G6
MO3/#WPLM;-TN=:F6\D'/V= 1$#[GJWZ#V-9RJ1CN!YMHWAW5=?F":?:/(F<-
M,>(T^K=/PZ^U>K:!\,]*TO;-J!_M"Y'.'&(U/LO?\<UULT]CI%AOE>"TM(5Q
MSA%4>@_PKS?7_BNQ+0:%;@#I]IN%Z_[J?U/Y5@YSJ:1V&>BW^IZ=HUJ);VZ@
MM80,+O(&?8#J?H*\\UWXL;7:'0[967_GYN >?HG^/Y5YK>WMUJ-V]W>3O/<.
M<L[GG_ZP]A4%7&A%;ZB-#5=<U/6YA+J-Y).0<JK'"K]%' K/HHKH2ML 45?T
MW0]4UA]NG6$]P.F]5P@^K'@?G7>Z5\(Y7"R:OJ(CSUAM1DC_ (&W'Z'ZU$IQ
MCNP/,^X'<]*Z?1O .OZR!(MK]EA_YZ764S]!C)_+%>Q:-X6T;04'V&RC$HZS
M.-TA_P"!'G\!Q6E=7=M90-/=3Q01+U>1@H'XFN>6(Z10SA]'^%6E6;++J4\E
M](/X,;(_R')_/\*[>TLK6P@$-I;Q01#HD2!1^E<1K?Q3TNS5HM*C:^GZ;R"D
M0_$\G\!CWK@-5\>>(M6#+)?FWA;_ )96H\L?G][\S4^SJ3^(#VG4O$>C:1D7
MVHV\+C_EF7R__?(Y_2N1U#XM:9"S+86-Q=$='<B)3^>3^E>26]M-=.5MH))F
MSR(D+']*W;+P-XEO@K1Z3-&A_BG*QX_!B#^E:*C"/Q,1KWWQ4UZY.+6.VM%_
MV4WM^;<?I6#=>+_$5Z?WVL7>/2-_+'_CN*Z2T^$VM3<W5Y9VZ^BEI&_+ 'ZU
MMVGPAL4_X_=6N93_ -,(UC_GNI\U*.P'E<MU<SG,UQ-*3_?D+?SJ':N>0/RK
MW6V^&OABWP6LI)V'>6=S^@('Z5IQ>$/#L0PNB6/_  *%6_G1]8BMD!\[[5]!
M^53P7EU;$&WNIX2.\<A7^1KZ('AW0U^[HVGCZ6J?X4C^&M!D^_HNG'W^S)_A
M2^L+L!XG8^.?$EA@1ZI+(O\ =G D'YMS^M=3I7Q;N4=4U;3TDC[R6IVM_P!\
ML<'\Q7:7/@+PQ=??TF)#ZQ,T?_H)%8E]\)]%G#&SNKNU?L"PD0?@1G]:GGI2
MW0SH]'\7:'KA5+*^3SC_ ,L9/D?\CU_#-;=>.:A\*-9M09+&[M[S;R!S$Y/L
M#D?K3].\<>)/"TR6GB"TN)[?H/M"E9!_NOT?\<_45#I)_ [@>P450TC6+'7-
M/2]L)A)&W4?Q(?[K#L:OU@U;< HHHH ***\ZD^-?A**:2)O[0W(Q4XMNX./6
MKC"4_A5PN>BT5YO_ ,+O\(?]1#_P&_\ KT'XX>$ "3_:''_3M_\ 7J_85?Y6
M*Z/2**Q?$7BG3O"^BIJNH^=]F9U0>4FYLMTX_"N1_P"%W^$/^HA_X#?_ %ZF
M-*<E>*"YZ117!V'QA\&7TPB;49+1CT-U R+^+8*C\2*[F&:*Y@2:"5)8I%#)
M(C!E8'H01U%*4)1^)6&/HK$USQ9H_A]#]MNE,W:WB(:0_P# <\?4X%>8>)?B
M_?>2RZ?;BRA8[1)P\I^G9?U^M5"E.>R ]9U;7M+T2+S-1O8H,C*H3EF^BCDU
MYCX@^*=]=,\&C1BT@Z"=P&D8>PZ+^I^E>=1WIU$&[:221Y#\SRG+$^Y-$TJP
MPM(P)51DX]*ZHT%%ZZL5R>XN)KN=Y[B:2:9SEI)&+,3[DU'5.WU.WNIA%'NW
M$9&X8JX2 ,DX%;M-:, HK3TW0[G4-2M;%Y;>SENL&'[9*(C(#W13\S_\!!KU
M/1OA9I%CMDU&62_E'\)^2/\ [Y')_$_A64ZD8;@>6:3X?U77)-NG64DRYP9,
M81?JQXKTK0/A796R)-K<GVJ?KY,;$1#ZG@M^@]JVO$OCGP]X(-I:7QD0RJWE
MPVT0;8JXZ@=!SQ]#Z5Q6I?&*74%<:!:^3"#M\^Z7+D^H4' _'/TK)NK-7BK(
M#TZ6XTGP[IX\Q[6PM$X5>$'X#N?I7"Z_\5H$C>'0X&DDZ?:)UPH]PO4_CBO)
M]:\2RW5YYNHW4UW<XZDYVCT]!]!6:NNVQ.&CE4>N ?ZUI#"]7J%SH=3U?4-9
MN//U&[EN''3>>%^@Z#\*I5%:SQWNW[.3(S-M"A3DGTQ77Z9\._$>I!6:T6TB
M/\=TVP_]\C+?F!6C:COH!RM36MI<WLPAM+>6>4]$B0L?R%>E77@CPYX/T*76
M?$4UU>QP%!(L0VKEF"C"CD\L.]+8_%_P)IMN+>RMKNWB'\$=GM'\ZSYW)7A&
MX&+HWPPUG4"'ORNGP_[>'<_\!!X_$UW>D?#?0-+=)9(7O9EY#7)RN?\ =''Y
MYIV@?$OPKXCO%L[+4=EV_"0W$;1,Y]%+##'V!)KK:YJDZB=I: (J*B!$4*H&
M  , 4R>XAM86FGE2*)1EG=L ?C7-Z=X^T75/%EQX:M_M/]H0-(K[HL)E#AL'
M-=.55B"0"1R,CI63BXOWD,Y+4O$VM7;&'PUHDMRI'_'Y<@Q1_P# 0V"WU_G7
M-3?#[Q-XAN!=:_K$*O\ PJ 9-@] !A1^%=CXL\:Z3X,AMI=6^T;;EF6/R8]_
M*C)S^=;EI<QWMG!=19\N:-9$W#!P1D9_.M%*45=*WF!P]C\)]&@8->75U=_[
M.X1J?RY_6NAM/!GARRP8='M21T:5?,/YMFMVL>?Q-IMMXJM/#DDC?VA=6[7"
M  ;0JGH3G.3AB./X3^,\TY=0-9(TB0)&BHHZ!1@4ZBBLP"BO.+CXV>%K:ZFM
MY(=2WPR-&V(%QE20<?-[4ZV^-G@Z>4)++?6RG^.6U)'_ (YN/Z5M["K_ "L5
MT>BT55T[4K'5[*.]TZ[ANK:3[LL+AE/XCO5JL6K;C"BLO1]?L-=?4$LW8O87
M3VDZL "'7KWZ'L:U*;33LP"B@D $DX K*\/>(;#Q/I?]HZ:S/;>=)$K-CYBC
M%<C!/!QD>Q'2BSM<#5IDL,4\3131I)&W!5U!!_ T^BD!R$_@9+*_.I>&[Q]+
MNC]Z+&Z"0?W2O8?3IV%=#IMY<W$9BO[46UVGWU5]R./[R'N/K@COVRFE:S9:
MU%<R64F\6US+:RCNLB-@C^1'L15_ SG'-7)O:0!1114 %>.3? 2":XEE/B*4
M&1V?'V0<9.?[U>QU!<7MI:#-S=0PCK^\D"_SK2G4G#X6)JY\AW>E"V\57&BB
M8L(M0:R\W;@G$ICW8_#.*]<;]GZ!E(_X227D?\^@_P#BZ\OU:YA_X6)J%V'#
MP?VU+,'3Y@R?:"V1Z\5[AJ'Q<L8U9=.TZ>9^S3$(OY#)_E7IUYU5R\G];$I(
MC^-:>5\.8X\YVW<*Y]< UY;X"\%Z-XHL-1NM8UB734M'1%97C4-N!/.X'T[5
M>\>>-]6\2:-]ENQ;QVWG*XCB3'(SC)))[UR6A.B)-N90<C&32I1E&C:]G<'N
M6O%7A_2]'N?^)-JTNHVHX9Y(=A4^Q_B'O@?C5GPSXBU:UTF;2;?4;B&S$GFB
M*-RO+=>1SCC..F23W-9VL7L+V_V>-U=BP+;3D#%'AV)Y'F**S$X4!1DD_P"<
M5L[NG[P=39[D^O)KG=:N/-O!&#\L0Q^)Z_TKLI]"U>WTNYU&;3;B*UMHC+))
M,GEC ]-V,D],"N6\*Z)+XI\6V.F L/M,I:9PN=B %F/Y#'U(J:5M9=@9'H5Q
MMDDMR>&^9?KWKJ++1M0U@F*QL9[G=\I\M"5'U/0?C7+,DGA;Q:8[J!9FTV\V
MRQ.N1*JMR,>C+_.OJ&?Q3X<TC3H)7O[6"!XEDBBCQN*$9&$7GH1VK+$2<6G%
M7N-'RPL#:/XA6VU$-";:Y\JYP1E &P^.W3/M7U%HW@[P_H""Y@MU>0#/VFY8
M.P'J">%_ "OG7XB:A8ZOXUO]0L%<6]R$;#@ DA I.,]R*M7OB36-3\+Q27MU
M<300J($!X16 P.G&<#//-56A*K&+O82T&>+O%LNH?$N?7K5]R6=TBVG/!2)N
M,>S$,W_ J[35/B=KFL1#[)(EA;N,@0??(/JYY_+%>6V6AW]_I&H:G;P,UI8!
M//DR !N. /?\*[GX:>%D\6V=VKZDMM]B<!TV;F*,"0W48&0P_"G6A!13_ET!
M'":S<-<ZG*S,7(X+$Y)/4DGUR36MIZ20Z(TJ1LQ2-I6P,X'7)]!BLFRL6UOQ
M!;V%L6)O;I8D8=0&;&[\ <_A7UA/X=TY_#EUH<%O%;VEQ;O;E8T P&4KGCO1
M7JJFHQ!:GRYX4\-7GC'Q"NEVL\44K(TTDLN<*H(R>.IRPX]Z]67X 67V7#^(
M+K[3C[P@7RQ_P'J?^^A7F%O-K_PV\7EB@@U"VRC"1,QSQGN/5&P#D<\=B"*]
MK\)?&+1?$$T5EJ,9TN^?"KYK@PNWHK\8)]"!Z#-+$2K+WJ>P*W4T_AWX&D\$
MV%[;7%S;WDDUQYD<\<6QMFT#!!SCD'N>M=I117E3DYOF>Y9PGQC_ .27:K_U
MTM__ $?'6'\+?!_AO6/A[87NI:'87=U)).'FF@5F8"5P,D^@ 'X5N?&/_DEV
MJ_\ 72W_ /1\=)\&_P#DF&F_]=;C_P!'O74FUA[I]?T)ZG+?%/X:Z+8^&)=:
MT.QCLYK1E::.(D(\9(!(7. 02#D=@?;'8?"OQ#<^(O MM/>R&6[MI&M99"<E
MRN"I/N5*Y/KFJGQAUVVTKP+=6+L&NM1Q!#'GG&06;Z #\R!WIOP7TN;3?A_'
M-,I5KZX>Z52/X"%53^(0'\:)-RP]Y]] ZG$^#?\ DX/5_P#KM>_^A5[Q7SEI
MWB"P\,?&S6M4U)I%MDN;M"8T+G+-QP/I7I'_  NWP=_SUOO_  %:JQ%*<FG%
M7T0)G/?M!?\ (,T/_KK-_P"@K7JOA_\ Y%O2_P#KSB_] %>#?%GQUHOC&QTV
M/27G9K9Y&D\V$IP5 &,]>E>\^'_^1;TO_KSB_P#0!458N-&"?F"W+[NL<;.[
M!44$LQZ "OEW4/$=]J/CF7QQ$LGV*VU&)4D'1$&=J?\  D5L_P"\?6O;/BWK
M#Z/\/+\Q2>7)=E;4-G& WWO_ !P-6#I/@-%^!UQID\&+Z[@:_88^838#QC\
MJK^=5AW&G'GEU=O\P>IZJCK(BNC!E89!'0BEKS_X/>)/[=\$Q6LLFZZTTBV?
M)Y*8S&W_ 'SQ]5->@5RS@X2<7T*/$/A5H&CZYK?B[^UM+L[[R;P>7]I@639E
MYLXR.,X'Y"O0M1^&/@W4;5H#H-I;$CB6SC$+J?7*XS]#D>U<;\%V"ZUXT9B
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M%>NMINKW]U;3%=]O'#M43XY9=Q!P<<X Y&>>*^E-&T/3/#^GQV.EV<=M!&,
M*.3[DGDGW-?,GC;P_<>"?&TL-IYMM$L@N=/F4]%SD;3ZJ>/P'K7O_P /?&*>
M,O#274BA+^ ^3=H!@;\?>7_98<CTY':HQ:E**FG[HXG/_''4TM?!$=AN_>7U
MTB[?54^<G\"$_.N,^"C:+IEYJ>LZKJFGVDP46MNES<I&V#AG8!B.#\@S[&L?
MXQ>(!K/CB:VC?=;:8GV=/]_K(1^.!_P&M2T^!6NW5E!</J=C \L:N8G1RR$C
M.TX[CI5QC&%!1F[7%U*7QBCTFX\3P:OI&HV-XEY%MN!;7"2;9$P 2%)QE2/^
M^:]6^%.H6VL?#S3D8))+9!K2164';M/RC_O@J?QKRS7?@SK.A:%>:J^HV=PE
MI$97BB1PQ4=<9]!D_A5CX'^(/[.\53Z-,^(-2CS&">!,@)&/JN[_ +Y%%2,9
MT+0=^4%N:_QXT-(O[)UF"((I+6LNQ<#^\A/Y/7E9UB0^%!HC$F);_P"V+GH#
MY>S_ !_.OI;XEZ,=<\ :I;HF^:*/[1$!UW1_-C\0"/QKYR\&Z"?%'BS3=+VE
MH)90\Y'01+\S_F!M^K"KPLTZ7O?9![GN7@GP6J?"&32YU\JYUBW>>5B,%&D7
MY,CL54)QZ@UXGX;U^[\)W6M1$-'-<6,]BZC_ )9S=%/_  %@?SKZR      '
M0"OFOXQZ!_8WCA[N-<6^II]H7T\P<./_ $$_\"K'#5.><HRZZC:)?@IHPU'Q
MV+UTS%IMNTN?21OD7]"Y_"OI"O+_ (&:/]B\'W&J.H$FHW)*G'/EQ_(!_P!]
M>8?QKM_%>MOX<\,7^KQP+.UJ@<1,VT-R!C/..M8XF3G6LO0%L1>)O!NA^+8$
MCU:S$DD8(BG1BDD>?1AV]CD>U>$_$#X63^#[3^T;6]^VZ6SB-A*N)8R>F['#
M ^HQU''>O0].^.OANXC_ -/M+^RD[CRQ*OX%3G]*Y7XE_%'2?$^@#1]'AN'6
M259)9YDV !3D  \YSCTK6@J\)*-M =C:^"'BV]U%+SP]?S/.+6(36LCDEECS
MM9"?0$KCZD= ,>PUX9\!=%G;4=3UUT*VRQ?9(F(X=BP9L?3:OY^U>YUABDE5
M=AK8X3XQ_P#)+M5_ZZ6__H^.O+_!W@#Q9X@\,VVHZ5XF>QL96D58!=3)MVNR
MM\J\<D$_C7J'QC_Y)=JO_72W_P#1\=-^#7_),--_ZZW'_HYZUIS<,/==Q/<P
M=!^",$>I_;_$^JOJY&,0[6 8C^^S,68>W'OGI7K2(L:*B*%11A548 'H*6BN
M6I5E4=Y,:5CY[T#2K#6?CMK-EJ5I#=VS7%XQBF4,I(;@X->N_P#"N?!G_0LZ
M7_X#K7EW@W_DX/5_^NU[_P"A5[Q71B)R4DD^B$CP7XU^&M$T#3])?2-+M;)I
MI)1(8(PNX!1C./K7M/A__D6]+_Z\XO\ T 5Y5^T%_P @S0_^NLW_ *"M>DVF
MI6^C^!+;4KIMMO:Z<DTA]EC!X]Z51N5&'5W8+<\X^(6HV?B+XG:)X7N[N"#2
M[!A<7SS2*J%R-VPD_P"R /\ MJ?2O3?^$I\.8Q_;VE8]/MD?^->'^ _ X^)5
MWK6NZ[<74*/<_*;=E!:5OF8993\J@H!]?:NT_P"%"^&?^@AJW_?R/_XBM*L:
M2M"4MO(%<Y#PC?VO@GXQW&FVMU!-HVHR>1')#*K( YW1<CNK'R_^!$U]!5\^
M_$7X66?A#P]'K&CW=]((YU2<S.N8U;A74JHP=VT?C[5[3X2U=M>\):7JDF/-
MN+=6EV]/,'#8_P"! U&)Y9)5(N_3[@78\R^$EC;ZG>>/+"[C$MM<SB*5#_$K
M/."/R-<2O@#3-#^(R^'/$=S<VUA<'_0[V#8GFY/R;B5('=3Z-CL<UWWP5_Y#
MGC3_ *_$_P#1DU=%\5_!TOBOPP)+--VH6!:6%!UE4CYD^IP"/=1ZULZKA6<;
MV3M^2%;0Z7P]X9TCPMIYLM(M%@B9MSL26>1O5F/)_IVK+^)=]_9_PYUN4-AG
MMS"I]Y"$_P#9JP/A+X[_ .$CTK^Q]1ESJUDG!?@SQ#@-_O#@'\#WJ+XZWOV?
MP1;6@/\ Q]7J*P]556?^86N:-.7MU&6]RKZ&W\+]-CM?AEI4$D89;B)YG5AP
MPD9FY_ BO-[3Q#+\*+_Q9X;!9XROGZ42,@2, %SZX5ES_P!<CW(KV?PS!]F\
M*:/!C'EV4*X],(*X3XE_#>X\6>(]'O[+Y4=A:W[!@"D()8./< L/J5["KISB
MZDE/9B>VA)\$]$FT_P (S:I=;O.U2;SE+?>:,<*3ZY)9L^C"L#0H#I7[1NIP
M;=JW(D9?</&LA_4'\J]GM[>*TMHK>"-8X8D$<:+T50, #\*\B\7XT;X]^&-3
M)VQWD:0'W8EXO_:B44YNI.?FF#5CUVXGCM;:6XE;;'$A=R>P R:\*^%UY9:E
MXTUCQAKNHV=K.S,($N)T1MS]< GHJ;5!]S7??%OQ#_87@:YAB/\ I6HG[)$H
MZX8?.?P7/XD5SNF? C1I-+M7U*_U%;YHE,ZQ/&$5R.0,H3@'WHI<L:;<G:^@
M/<ZSQ=>>&O$WA;4-)?7M)#SQ'RF-Y'\L@Y0]>S 5S/P(U22?PWJ&E2OEK*YW
MHN<[5D!./?YE<_C4G_"A?#/_ $$-6_[^1_\ Q%8%G8P_"KXLZ?9PW,TFDZI
ML3-.1D%F(&< #AP/P8U453E3E3@[]=NP:WN>Y4445PE!1110!YC=?!;3;KQ)
M/K1U>]626]:\,01-H8R;]O3.,FO3J**N=24[<SV"QS_C'PI!XQT/^R[BZEMH
M_.67S(@"<KGCGZU2\#^ [7P/%>QVM]<70NV1F,RJ-NT$<8'O76T4>TER\E]
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M!1114@<5I/PXL])\<W?BF/4+F2>X>5C RKL7S#DX(&>*[6BBJE-RU8')^.?
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+XX[GK14U%2!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>tmb-20260219.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.4a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +aA5w7xRiXgen8uLa3ZcWaSPubOdzZR+OYkxtmBxbZn6jyArNLo8ECUnP2A2wW0N -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:srt-types="http://fasb.org/srt-types/2025" xmlns:tmb="http://onconova.com/20260219" elementFormDefault="qualified" targetNamespace="http://onconova.com/20260219">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://onconova.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="tmb-20260219_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="tmb-20260219_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd" />
    <import namespace="http://fasb.org/us-gaap/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd" />
    <import namespace="http://fasb.org/us-types/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2024-01-31" schemaLocation="https://www.xbrl.org/dtr/type/2024-01-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2025" schemaLocation="https://xbrl.sec.gov/country/2025/country-2025.xsd" />
    <import namespace="http://fasb.org/srt/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd" />
    <import namespace="http://fasb.org/srt-types/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>tmb-20260219_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.4a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>tmb-20260219_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.4a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="tmb-20260219.xsd#Cover" roleURI="http://onconova.com/role/Cover" />
    <link:presentationLink xlink:type="extended" xlink:role="http://onconova.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Feb. 19, 2026</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Feb. 19,  2026<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-36020<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Traws
Pharma, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001130598<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">22-3627252<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">12 Penns Trail<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Newtown<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">PA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">18940<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">267<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">759-3680<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common
    stock, par value $.01 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">TRAW<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="tm266824d1_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://onconova.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="tm266824d1_8k.htm">tm266824d1_8k.htm</File>
    <File>tmb-20260219.xsd</File>
    <File>tmb-20260219_lab.xml</File>
    <File>tmb-20260219_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "tm266824d1_8k.htm": {
   "nsprefix": "tmb",
   "nsuri": "http://onconova.com/20260219",
   "dts": {
    "inline": {
     "local": [
      "tm266824d1_8k.htm"
     ]
    },
    "schema": {
     "local": [
      "tmb-20260219.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "tmb-20260219_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "tmb-20260219_pre.xml"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 59,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2025": 22
   },
   "report": {
    "R1": {
     "role": "http://onconova.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2026-02-19",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tm266824d1_8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2026-02-19",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tm266824d1_8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://onconova.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://onconova.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://onconova.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://onconova.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://onconova.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CountryRegion",
     "presentation": [
      "http://onconova.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://onconova.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://onconova.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://onconova.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://onconova.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://onconova.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://onconova.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://onconova.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://onconova.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://onconova.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://onconova.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://onconova.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://onconova.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://onconova.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://onconova.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://onconova.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://onconova.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://onconova.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://onconova.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://onconova.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://onconova.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://onconova.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://onconova.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://onconova.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://onconova.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://onconova.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://onconova.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://onconova.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://onconova.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://onconova.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://onconova.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://onconova.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://onconova.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://onconova.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://onconova.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://onconova.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://onconova.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://onconova.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://onconova.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://onconova.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Extension",
     "presentation": [
      "http://onconova.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://onconova.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://onconova.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://onconova.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://onconova.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://onconova.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://onconova.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12gTitle",
     "presentation": [
      "http://onconova.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://onconova.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://onconova.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://onconova.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://onconova.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://onconova.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001104659-26-017298-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001104659-26-017298-xbrl.zip
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M9X -[VW3M7LO7[P\WO[@'K=]=T/_(]9]%\O?$<M>+993'E9XJS(>ET'TDM%
M;.[M[!ULU0<#+UQ3'V7<F0,H!J(AT+0<Q2H<),%(#Y(H'B1Z.D#$VMX_?'FX
M]^*G%]O?9??-9+=?R^YZK#\AD/+I$IDD)5=,'&-1HKR!\W)0[T[_URKG'.N<
M)#I7R%RX=>3.&W_A?V<J4 21V97W=QE$/N@YT+?"N3\,;BFS"DHZ1.)2F//'
M8,JIZ*F)8YTS(DMTMD[6?!TU^Q;#_JY9WT2S7K2<]34T"_9__]UTOQF##VH&
MTQDPFQ93EP+&\]]B\7]L2@9Y>C^5F1V*I%9V+F(+?L,Q(-]7*%!HM+.@<4K4
M::@K4"[EKJ!$B4Y'R=R!(A2XJ'"><,K_6?QD]1G YPFB-!M1!)R(!F! J?S2
M0<-NISYI:"MW.Z[X38X=\CCBND.' \=Y D(GA 7P>71?GW-]W"@[>\+W'^EZ
M5/43'ORP!X8F-(]"3W#M0A[4B)4J^#"1X,-$(O S$=69A1:FLT!<M_-1L0W4
M,V*6$:L: 8LP5+T-ZB#[&1J>U'18T!+V0X.*&C<7S%\BC,X>933W6?6<:F3>
M%^P\79RTF/ZJFF;<KC%6YE,3M5HU0"86NAZ$4C3J?CNK5L/N.JF1M@5@MN<T
MQ./05Y+1*W=V<Y.[)-A=JT\R$"L0P'54-$&EU1C$FDTN4E8#28%,UT&'FZ?G
M[Y[A@0)G7KD[\H?2(5>*V\XMAG)C-(Y5%FBL8-$MFE?/"G+LMBT/%8[41 ;S
MVI^8)#"1F<SMJ)*,Z:4->@*!( 2/>-5$9O*3##1N&0W$%4W_AJJ0.LK![(2@
MU[$=DTZ$.SW-;10Q4Z-<%XH/OC8*E]EL-M#9H*!+K0_C$M01BFU1]O/\I(3<
MWTY&-S",GDBMYCUH<$+0SA>V;;M88Q-%9B;@%\##2R2 *KQXRF=MOPQ]>_$=
M?7L6Z-OZQ HZ/9/(,2^-87_#<S+D;?)GF57=FKAJIN355FP6H>F\G#56/K?O
M=A[9G2-2U==3Q>TR#W<$B\]CV#D5NY.]GX;^08V*?!APAK)[N+]O1\9C1@-Z
M"_?NGJ^XUU?RW4Z]RHOV*OYHTW6FZ24#S;LOZ\FT&]+\N*;E\*#GVAH/=%J0
M.[L6/*!!^XS.TA2V(>3[#S4KZ!5($[#)1V$W%M;C0#.B_C6-OMJQ'*Y/*&"$
M.K335LV#:,U^2*N7X_H[]#:FGC_F1H>O_(L0Z D]B*=Q\'SA!1>MQ)*FKFPL
M;!VEI;N6LA;F[@PY*OU;W]@(HCYDVDE"M_MNASJ&L@"/4I>%:\I%H(*+:M74
M0AK04UFL$QN-:^:X62O7XLD77UCB6V5+/U#R&NBT^5,U4Z@>J>Q;NH4WN?BE
M&XY<_#J6\\6O>*QCZ3IZW]OBES,=14M$V2'T)9H@(PVV$%RUN'5W @]<6MI\
M<]BB\3H78^<V$5Q<[AT8U 'SAJ[/>8YC7!8TV>T. ]*-_NR<&$8TKC.9NK+'
MRZ6>K[?,=:>>,L43;/;E63P0\Q<Z(/F-6YSK\E%,Z4MU/G8&Q0QI%+^YO#\1
MRK.O7)CP"03:=V:G8JJ34[[9JZHW?&$E]SHC4FLZ"46G+.8M,L4*#\CJGJM%
MRDU"W6G[=BE[XJOA5NX3ZJ!;MV+_9D?3:WL9:\!62&.DNR9;]!.0CI5$-67G
MTTV>'K8MV H3?7,V7/0S\(G,#1[G;$T0KQX]/K+AH@P"[\L*4L<)JTF+@&HU
M?OM&?K3@UA05AN0U%HY_KIQ,J%]EL\Y+%GZ8ASKT;B#'W]@<XFE,Z"Q2M.@&
ML215L=[G2FPY+>RA/CWFM693E33=J3V-3X498H$9V8.7/5(GGLE@.=$S$X1M
M/J=*&D731M"7HS;WFH->"P+DV6-;"(+UU/^GY VQO28EIZG-*))(&ZUE''4[
M;AMTRD/;[YJDNY&VN'IE(LU5S.C<#[]TRVW,LLQ/%"=*635Q)TJK\]"U-"S@
M;]_ZP[+N=E:-5OE3PN"0)EQ@U4#547W<I*C2%MB7]"M8=,'^X.OEHY7SV8',
MIZ@%,_.'>XG; O/]X57:AM24 ]6'Z/@%@(2^D.R) RH\<@10V1[J/"C9B=A#
M-#RI AH;H>N&]O;&FG-U@D4O5(O6=/.O[V=LWIZ?;L$M)W\97NEHC'WGX4*Z
M!\>6HB*PWDM6+\(BA^N1+=Y8(>]YWER84>1S*;"KY%.60O[-IUO%X1#1[=31
M)M!94,8Y&Q^^",AI\4@['TGS]#D[<_=;30VL?[/'F,ND3@+\R?8>'YU+"W^L
MS.F7,P?R_]U.)&=/N/K\BU.P3=CTE'@>%*^>=JFR<7(*<B-<?TWN*ON&"Z\%
MQ+\="O#A)$B9['\LX!JV@_5TF;X"BGFZY*Y7^ L&L>$&GHNR_\M,$_$FDY3U
MY<>O;[#NI1ZKVT#3>22=<\)W>7EJ?SK<_:F_?W#0W]L_/+#?0./^&+O;_Q'A
MSCS0TMWX7]2[ZK(O0\(.CL1[>QCEE;B4>?%T@+'/HU2-K2YP8YM>BF[?DDXO
M4_]_4$L#!!0    ( %!%4URKG#;-*0,  -\+   0    =&UB+3(P,C8P,C$Y
M+GAS9+56VW+:,!!][TS_0?5KQA<@T$"@&4J:#C/D,M!<FI>.L 51(TNN) >G
M7U_)MLS%0("V/,F[YYS=]>[*M,^2D( 7Q 5FM&-5',\"B/HLP'3:L6Y'=G?4
MZ_<M</;I_3N@?NT/M@TN,")!"YPSW^[3"3L%5S!$+? 54<2A9/P4W$$2:PN[
MP 1QT&-A1)!$RI%%:H&&<PR!;>\@>X=HP/CML%_(/DD9B9;KSF8SA[(7.&/\
M63@^"W<3'$DH8U&H>8F7_W:C7V+A%^0CV*W//B9#_#!%]"0>P-JC?P]'-_'X
M.OC].#RZ_OZ<R/!S,GZDC9^O77XU8"=?>K?TIMJMSNZ]JRQD6_A/*(1 ]8**
MCJ7KR\N;U1S&IV[5\RKNP^5@E.*L#-A*"*;/Z^"59K/IIEX#+2&3,2=&NN9J
M]Q@*5"@K+]Z"QU1(2/TE?" +PB*X[F;.)2A>"VUD4&R@ 5K!">0[4_;B*H?"
M5^L&& M["F%4@"=0C%/1W+$$%ER6@<JX"K+E:X3$6FCF6B+(<%Q F5H@/9=Z
M)#6HX54K3;57!(6(R@O&PW,T@3%1>?R*(<$3C (+2,BG2.H9$Q'TT1MJ9E A
MI4S-L]JIW*)M4835P!8&9=(-;G%&T#>5.= 'M5#K0VBGVV/J3K  #CI6=EP0
M,W(!FF"*T]#Y E6 K=<EUF6J8\ILNZO@LE(L4'!-/Z7GB".AZ&E) V7(^3ED
M.]>'Q(_)0=1Y?MN8N=V\R-(;-GLT1!.0[E]+3TK'$EA?@%9N>^)HTK'4Q-BF
MG3]4U8X:)(/0 ;:L7]JBU1>5QS42D/LEE=+UH$18A+C$:IH7[H L<RPU_68A
M#-!QA 7<?U<X@>-]"U<41/YCQ0.M7RZU[2[OE7I>W;VVJI9Q"6AIB;==H=GE
M/V!^*K6%HI]LP[.UR:Y4[5K%240PSW2?).9O8+\D#.^ )#9<Y.OBBTUP?= C
M5-\UZ(8/PM:@:SDN(E(8R\$I+'X^_B*'5&:O));:&4CN:@DM>FQ[%=7$S>F\
MQ4R?Q4%#X+.82OZZSR L4LS#8=V8?_AW:X3!9TW0_P4.#7O %)2#KQN!MINI
MJ>,?4$L#!!0    ( %!%4UQ5&@"@_0H  '^&   4    =&UB+3(P,C8P,C$Y
M7VQA8BYX;6S-G5UOX[@5AN\+]#^P[DT+C..)TRZ0[&07&4^R,#:;I+%GMNVB
M6- 2XPBAR8"2$_O?EY1$6:)X)"5%2<[%C$=\#_52?$Q27\>??MQM*'HA(DTX
M.Q\='WT<(<(B'B=L?3[ZNAA?+&;S^0BE&68QIIR1\Q'CHQ]_^.,?D/SSZ4_C
M,;I*"(W/T!<>C>?L@7^/;O"&G*&?"","9UQ\C[YANE5;^%5"B4 SOGFF)".R
MH-CQ&?KNZ&\8C<<#JOU&6,S%U_MY5>UCECVG9Y/)Z^OK$>,O^)6+I_0HXIMA
M%2XRG&W3JK:/NX_EGR+\$TW8TYGZ:X53@N3A8NG9+DW.1VJ_Y6Y?3XZX6$^F
M'S\>3_[YR_4B>B0;/$Z8.FP1&>DH58LM[OCT]'22EVII2[E;":KW<3+1=JJ:
M96G2H:\Y29.S-+=WS2.<Y;W>NQL$*M3_QEHV5IO&Q]/QR?'1+HU'^N#G1U!P
M2N[) \J;>9;MGR5)::) &)7;'@5YL)NA0DQ4_(21-<Y(K'9TJG9T_)W:T9_+
MS==X1>@(*:7D VS7::.N,FCBVNP=$0F/+]G[7)O1GNS+[X[(_H<&U..=-V')
M,TS?9;X>Z=SV#7G?$3_$N3_2<I@G[SO2M<C_B^VL;?G-A]=^7*G:>"T_-2R2
M728G,!)KDZJ*CA$XWT,^,91U5[7SJ%$O5:,Y%^VVJYDQKS,ET=&:OTQBDLBZ
MIW]7'\;J0]YL^9_?9UPN!"Y6:29PE.F:\F:<CRSE$].24EX([0N+J*=QI6(2
M<3DU/6=C6AS&(OQ!\(UUMV6KN:7P=[JJXHO#(G<!&&W(!$GY5D3D3;U2=PL=
MI=+1ADJ%6E$1-OZZ&/V0:]!O6O6?3Y-#+0XZ6BZ!MAO"LJ6LT=*"9K&K;K:9
MTKU<+PNBDRV&S#[6$J0TCCOX0NXX5CN_HGAML6^4N^IBJRW=QXW"(#K9YLCL
MY4J#E,A7-W\A:2229[6<[VI'0^:\TRTF6WU?TX2%0-L83$)-ZVE@OR?K1$TM
MRH(ZOR5J8\<P!NA=#_V=MLVYP"H. IHA#L'9HAZ$JBA/'%TPML7TGCQST85/
M4^::&IM)$Y:Z)BA&+,9 - HM*L2>B/C'5IZQ$T'WO5"TE*ZY *R::!BRH.BP
M>P,!J>1^&5D*S-)$#6"]D+2ESD\W +.M4P]#%Q0G@#GXE*32^R5E\4@H5;<#
M,.L?4&QBU[3 ADU>VLJ@B 'M@<SD$:@,"0>;RQ>U.I?+I(&-K>E]PM.RW<5/
M)0X6(=/A0(KR,*3B/)%4NPW1PU!+Z9H>P*K)C2$+BAB[-Y"50HYRO7](+ED\
M")%*YP<0PZ8=CU(4(!Q-9WUH2+5/,*Z2-,*T\'(EMZ4=S;-H70,"VC4A:0F#
M @5R!\)2!&AF\A"OP/R+8#$,EYK2#RPMJW94*EF H)C>^C!1>B^0S+9"-%S#
M,PXL=793ML=L=7\6T 4!2H^YUEW;0MX Q=,,=,FR)-NKQ^ENMIL5$9;&M26N
MV(#,:2;,\B!8 $R9#!0RI'2H$'KI>7V7@&7J(4:P.:;,+0%VDTT*FIJ 2+ :
M V@X:/-G2KT0,9,CD\!TSF*R^YGLP7:U=&Z9 &PVH3!$ 5%A=P9@48I1KD92
M[@6,.Y%LL-@ODJAGJF@+W:(!&6VR8:H"@@.P!M!1JM%B/O,YDRSQ;AY+4).'
MI'@>O(<24.\6EA[;368 <4#H=#L$"))!J!GE$Z0YB[AXYK7''69\*P? _8S'
M\ JE)\HM5(.:T$2K,R0@P(;X!#!KA'XHGDE!7+W&DU> 5 U>B+N(8WF@TO*?
MZX218[#]5JU;NCKL-IFR" ,B"78'\%,J/^@/2,6@6Q8*--,W-'7J'YKI4&BF
M04,S?0\TRU<>"#0G;VCJB7]H3H9"<Q(T-"?O@D9VO->Q9B8_WHHE?[4]G TJ
MO2#3MFH%YB +#Y>6MSY85(!:SZ@0GYCD"ZM;<2?X2\(B>,D,R;T  YBV4F-H
MPT/';K"/GVI!K..\CC7%HKSW2Z)E?D:9IDG[$%-HPH.D::QW<"G4/I&XXVF&
MZ;^3Y\X3<;O8"QY6PU9(&LKP4+'9ZP.FB$$RR,>)=8FKNJ%A?97,*'?W"K#%
MUN$5X%IA$!#8'+5? 2ZNGA0BU]VL&!4$ R-"L]A9)UM,57U<*PNCB]N&6CV<
M?Z^EQL<7665WH7>/G,$/"+0EKGH:,J=[VRP/HL<!4V:OYS*4ZSQ=C5<9)E+[
M\%TK<S:SFW:JB5P7!-&[IIO6-*W+'??FKR+)Y)YG?+/9LO(NC^VY04#GJI<[
M;>H>MXJ"Z/TN9R8)I18UQ8ZQ6'":1$F6L/4O\N13)-C6*IO(%1"P04U#6Q$$
M"J MDX.#$&FE8PCN!%$0$MD1^4N *K&0N'UXL,[V76)74/0;UG# RB @Z;5G
MPB(#QE$M A4A*(_QB\T\3;=$O D>2X@GA$#S $@M?8@X029[H2H"?;*U(-%6
MSH_[X^EJF634=G+9ECB;DP!SU8QDE ?!!F#*9"$O0_P!'4__LOHKTE&.N_^&
M+P56N6,7^\V*4R#[E%7E"H(.BYH#BR0(%&!?)@TW')525&A]9*=JF+4TQRAW
M!8#5EN[Z1F$0G6YSU/KR-_K:TY!_N8L>I2D"O)!@E[D>^FTFS>&_K@D"@0YC
MK9.24HJTUL<+"8<I:]V_"%A[6P2L>Q8!ZQ 7 >NABX"UMT6 WFV1(D2.2[<K
MFJPQD)RP4^T:B@[+)A\6:5"HP/[ ,:,*08<8UQDM\Q1G*CV_V.3[OY(?+*T$
M=,YR6G;9K)):VD1!,-+EK)76LD@Z5Q,CI7;-Q39.,A(79JX2AEF48%JE1[1=
M$>\/<4;+0/,5.#WZ,!@:9K*%4Q&F<QE6@8=4EZXOI1</8/Q**/V9\5>V(#CE
MC,3%M13;G:)NO=LG9GIL-Q^: <1!X#3$(?#HC H:/ZDHI,/**V%>2/K&Z99E
M6.3OD@O;R 3HW)(#V&P28X@"(L7N#""D$J-"[><%[2)[1+7(*GYW"&P@)'?\
MNG:G:>.M;:LV(&8Z#4+O<)<Y/PYKXR+*TRN6&5&_%Y&\D"\XPZ4WL+V0W/5+
ME5VFS;<I;=J $.HT"+X_6<6H5#%8,^4M98R8R:76FG<\)6ZHW">.:5ELYXZI
M) 'A8?/5D4%&(*WUPL)B@RG]O$T31E)X(C)4;EFP6FRRT) $Q(+-%\!"+D5:
MZX6%RPT1:SF]_23X:_98YF<%VP:HW;+1:;G)B%4:$"M=_@!F= @J8G1*73_P
M[ X)Q8LLBW!++5+'V(!F#69:NI" @<RU:*$D4M=;;GB&EAQ]30G*'@FZ+'^&
MKIX)OJC'UR^-1)%Z(:)8E;,8"QM"76+GOSH"&F[]]DA+&01(O?;@WR&I(I .
M<4S-K618U,_C<A/SC&S MQWZ0UP1--2\YJA/'P1- TV:3.5AS9/K/!"I2)_9
MC.K)[>$E7D/D>&5L,6@LC&N*(!@!;4'+XOIO!?C)G;==T22ZHAS#5UD:&L<9
M\]KVC&1Y!T% !+1=02GR<B'*E5[Z_S-F3V+[G$7[.\$C0M135FDU6O5=?QL8
M[9:9-S6I2=.@T( X>XM?@,!#%:A6QX?:C.7S8IYZ:%QE<^/1T^(1RP-XN\U2
M-8-*8_!5\,X@Q[<7!C3 N,G0$1$0>@-L0C<<\DB4AWY 13"J17LZ/TL/60!)
M_'E_3QZ(4.\=+,DN^RQW]-1QAC$@UO79V^#FF"=SO8%!0/A6M]"I7HKJ%:"5
M>D:LK +]IBI!>2VVWR^O;[J6G^1FO4G^M<(ID5O^"U!+ P04    " !015-<
MBGCD^UH'  #35P  %    '1M8BTR,#(V,#(Q.5]P<F4N>&ULS9S?<]HX$,??
M;^;^!Q_W3 BD[5UH<IV4A@[3M,F%M+V[EXZP!6@B2XPD!_CO3[(QY8<E;UZ\
MR4-"S$K:[V=EV6M)OGBW2GGT1)5F4ERVNB>GK8B*6"9,S"Y;7\?MJ_%@-&I%
MVA"1$"X%O6P)V7KWUZ^_1/;GXK=V.QHRRI-^]$'&[9&8RK?1%Y+2?O21"JJ(
MD>IM](WPS!V10\:IB@8R77!JJ/VB:+@?O3EY1:)V&U#M-RH2J;[>C[;5SHU9
MZ'ZGLUPN3X1\(DNI'O5)+%-8A6-#3*:WM9VN3C<_1?$+SL1CW_V:$$TCBTOH
M_DJSRY9K=]/L\NQ$JEFG=WK:[?SS^68<SVE*VDPX;#%ME:5<+57ENN?GYYW\
MV]+TR'(U4;QLXZQ3NK.MV7[+ O8[GFC6U[E[-S(F)H]Z;3.1U\+]UR[-VNY0
MN]MKGW5/5CIIE?!S@DIR>D^G42ZS;]8+VY,T<QVAM3DV5W1ZV3+IQ-;3>W/:
MZYZ[6GX?2-L]6Y$K;Z.^]5;:7NJB[0+=<5]V-H:=O687BFHJ3*[TQA[8:Y^N
MC.U--"D]<-74-["I@1EGO.DKW:CM.E:6VK;LQ\)RXTCI"I?Q7NO<!4"J??EE
M9\XQ:QJ?S.13)Z',XNZ]=A\<G-<Y&/O/C[RAJXDVBL2FK(F3">5Y_3^LS8%)
MIP&O2A(/ML9JI_8M#GW:#=J5BB.I$JHLZ[(NHN*]4!WWRXU%9T&4K:@=SQG?
M1GFJ9.JCLR$A/8[N@K)--$/SRK:?.!^&G,RJ<1Z8 'EV,8!6JL$B^H'J6+&%
MXU(#=L\2R+>'RK="6\.8RW/GGLZ8\]>YXJZVU!T,CPN>(D#P9Y@C15 M4@2N
MA,@(OZ<+J6K [UL">;_"Y%VE#0GSWQE1ABJ^AI ^,@;"?HT)VZ,0B?>#(D(S
MQP<"_-@:2/P-ZHV'1R,2\O&<<NX2.") O;S*'HC]#TSL?ITO /SUD[N^VTL+
MG/U.$2#^/U\*_B.U2!&XHXK)Q%[2%8#]D3&0^CDF=8]"5-[7(H'2WIJ"\Q]\
MV ?RD% /F8X)+SP:VF,ZC+O"'(H<)>>LE8F*_5]*%!CZCC$4.4H:6B.Q8>"#
M3*D]9X*CBM\:BAPE :T3V3#S:V&86;LG_E^R=/+SP>D^ZV,K*&.4I-,G"H5M
M^:1!&#>3$>)[: EEC))KAL2A<!Y8/8KPD4CHZA-=AT ?F4))H^2807DHJ.\4
M2XE:CUE</V@<VT)AHV2688$HM!_(:I1856S*BKG >NC>(E#V*&DE2"Y*"$8B
MEFHA=QX7#V1FS\?U0";!(;VF(#0<*/GF,Z2C!.4J22PNO?ESPP3MAD)1:0Z>
M(\(+0$#F"\'>>Q[V'AP[2AY:*_.%8#]['O8S.':47+16)B;V@?UXJQ[DTC,#
M[36&(D?)16LD8@+/KS2WZD[))U8LB:JC?E0"BAXQ10V+1>WPQ44>TMM+2RAO
MQ'2U6APFYSNI#>'_L47=G62U/90Y8N(:$MKT \8B[NZAA6\IT8$)E"]*KEHI
MIVFD+L**$G_WW;>  D5)0*O$-,SS1KJYC[D4P>>QQU90KBB9I$]4TP.O6TBL
MO:?^SM?@%6PHP^JAC(8Q?E?,6 \&,DTSL7E&XYD5\YA"\:*D?T%Y#:,>2\YB
M9IB8?;9WB(H17LVYR@X*&279\PMKF/"=HB[2U-YVY^NXW$X#=3N=^D;>D#V4
M.$JN5R\4E_Q(ZXRJY_*O* 6- DK:!Q7=]#A#X\P.>^MN;_+@=LQX1IDC*RAK
ME)3/)ZIAME_D@R)NI]YXG4XD]V\/J32$$D9)\ +2&H:\YT<UW@,3*%B4S*Y2
M#M*8<+V*YT3,J'_U0K4E%#!*IA<2AS;VSD!C[^R98R]*QN<3A<2V6!MNSZC;
M"6<SXM])%BP WF>#23P@M>G]>_F6'[>)6Z6Y'T/[H1J[QQ0*'&>+9$A>TZBS
MA!F:%"X-F2 BMBG5=E^;)SNO+P4- ,X>2J!HE,?[WRGGGX1<BC$E6@J:%+?Z
MH2?\WB+0*"#.(=;(10G!-\DS2TGE"T&5YQSPF$*1(\X=>N3AK+TL%C5OKSW%
MVSI"Q'TEH. 1)Q'#8I'6IQGJ?&9/] ,Q9.-AB+^O!)0_XH1B6"S:^GDUL!>>
MF0S/F1\80FDC+H6ME(8">9P2SM]GF@FJ@V/+@2$4,N*:UTII*)"O4ZIF=E#[
MJ.32S#=[.T.P/06@T!%7M@:EXL!?_=Q'7NQ_"Y*OL :_G0 1NU<DUFLWXM@M
MI"BNY"(ARD,]9 _ECKJQTB^T8?*W9D[5[OU3[LS(YFVA10_UI:!10$E7H:)Q
MKJT[._F#E]8].RAOQ,2T2AC.GJELPED\Y)($[\OWS*!\$;/0"EDH>-\3\:BR
MA8G7=TK&E+KI$[T]VP )$; ":$@0\]-GH<!Y7"#3U&TFDO'C>&Y%Z]O,Y.\N
MM?X%'QH$RT%#@[F)$R <Z2Y(_]SH19/WZWLZI<HM4WB@*_/>-O08OBD"%(?&
M!_6-0F ,%6&ZZ!SINK$'W.MIBV_<+_<*5GOD?U!+ 0(4 Q0    ( %!%4URU
M3X$'@!0  !!I   1              "  0    !T;3(V-C@R-&0Q7SAK+FAT
M;5!+ 0(4 Q0    ( %!%4USGZ$@S3A@  %-=   5              "  :\4
M  !T;3(V-C@R-&0Q7V5X.3DM,2YH=&U02P$"% ,4    " !015-<JYPVS2D#
M  #?"P  $               @ $P+0  =&UB+3(P,C8P,C$Y+GAS9%!+ 0(4
M Q0    ( %!%4UQ5&@"@_0H  '^&   4              "  8<P  !T;6(M
M,C R-C R,3E?;&%B+GAM;%!+ 0(4 Q0    ( %!%4UR*>.3[6@<  --7   4
M              "  ;8[  !T;6(M,C R-C R,3E?<')E+GAM;%!+!08
.!0 % $0!  !"0P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>tm266824d1_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="tmb-20260219.xsd" xlink:type="simple"/>
    <context id="AsOf2026-02-19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001130598</identifier>
        </entity>
        <period>
            <startDate>2026-02-19</startDate>
            <endDate>2026-02-19</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="AsOf2026-02-19" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2026-02-19" id="Fact000004">0001130598</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2026-02-19" id="Fact000009">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2026-02-19" id="Fact000010">2026-02-19</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2026-02-19" id="Fact000011">Traws Pharma, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2026-02-19" id="Fact000012">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2026-02-19" id="Fact000013">001-36020</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2026-02-19" id="Fact000014">22-3627252</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2026-02-19" id="Fact000015">12 Penns Trail</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="AsOf2026-02-19" id="Fact000016">Newtown</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2026-02-19" id="Fact000017">PA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2026-02-19" id="Fact000018">18940</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2026-02-19" id="Fact000019">267</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2026-02-19" id="Fact000020">759-3680</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2026-02-19" id="Fact000021">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2026-02-19" id="Fact000022">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2026-02-19" id="Fact000023">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2026-02-19" id="Fact000024">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="AsOf2026-02-19" id="Fact000025">Common     stock, par value $.01 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="AsOf2026-02-19" id="Fact000026">TRAW</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="AsOf2026-02-19" id="Fact000027">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2026-02-19" id="Fact000028">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
